A group of Leridan scientists work on a project on the consequences of type 2 diabetes mellitus in the lungs and how to improve glycemic control, benefits are obtained in lung function.
Researchers from the Basic and Clinical Group of Immunology and Endocrinology of the Biomedical Search Institute of Lleidlung function and breathing during sleep.
This is a project led by the group's principal researcher and head of the HUAV Endocrinology Service and professor at the UDL School of Medicine, Albert Lecube.
"Our previous work has evidenced the negative effect that type 2 diabetes mellitus exercises both the lung function and on night breathing. And that is why we now want to demonstrate that improving the glycemic control of diabetesPulmonary, "explained Dr. Albert Lecube.
Diabetic patients can present more easily than the population without diabetes a reduced respiratory capacity and the final objective of the research is to identify the lung as the new target organ of diabetes complications.
For this reason, from the Endocrinology and Nutrition Service, and with the firm support of the Pneumology Service, the HUAV sponsors and directs a multicenter clinical trial that includes centers from all over Spain, with the aim of studying the differential effect on lung functionof the various drugs used to treat diabetes.
This essay has already been approved by the Spanish Medicine Agency and is expected to include the first patient during the month of July.
This Irblleida search group is the first to study the bidirectional relationship between diabetes and lung diseases.
At the moment the commission of a review entrusted by Lancet Respiratory Medicine of the Test due to its great international impact.
